Please use this identifier to cite or link to this item:
doi:10.22028/D291-42284
Title: | Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil |
Author(s): | Manier, Sascha K. Mumber, Paula Zapp, Josef Eckstein, Niels Meyer, Markus R. |
Language: | English |
Title: | Metabolites |
Volume: | 14 |
Issue: | 6 |
Publisher/Platform: | MDPI |
Year of Publication: | 2024 |
Free key words: | HPLC-HRMS/MS new psychoactive substances indatraline troparil metabolism |
DDC notations: | 500 Science |
Publikation type: | Journal Article |
Abstract: | With a rising demand of cocaine over the last years, it is likely that unregulated new psychoactive substances with similar effects such as indatraline ((1R,3S)-3-(3,4-dichlorophenyl)- N-methyl-2,3-dihydro-1H-inden-1-amine) and troparil (Methyl (1R,2S,3S,5S)-8-methyl-3-phenyl-8- azabicyclo[3.2.1]octane-2-carboxylate) become popular as well. Both substances share a similar pharmacological profile as cocaine, while their potency is higher, and their duration of action is longer. This study investigated their metabolic fate in rat urine and incubations using pooled human liver S9 fraction (pHLS9). Indatraline formed two phase I and four phase II metabolites, with aromatic hydroxylation and glucuronidation being the main metabolic steps. All metabolites were detected in rat urine, while the parent compound was not detectable. Although low in abundance, indatraline metabolites were well identifiable due to their specific isotopic patterns caused by chlorine. Troparil formed four phase I and three phase II metabolites, with demethylation being the main metabolic step. Hydroxylation of the tropane ring, the phenyl ring, and combinations of these steps, as well as glucuronidation, were found. Phase I metabolites were detectable in rat urine and pHLS9, while phase II metabolites were only detectable in rat urine. |
DOI of the first publication: | 10.3390/metabo14060342 |
URL of the first publication: | https://doi.org/10.3390/metabo14060342 |
Link to this record: | urn:nbn:de:bsz:291--ds-422849 hdl:20.500.11880/37982 http://dx.doi.org/10.22028/D291-42284 |
ISSN: | 2218-1989 |
Date of registration: | 1-Jul-2024 |
Description of the related object: | Supplementary Materials |
Related object: | https://www.mdpi.com/article/10.3390/metabo14060342/s1 |
Faculty: | M - Medizinische Fakultät NT - Naturwissenschaftlich- Technische Fakultät |
Department: | M - Experimentelle und Klinische Pharmakologie und Toxikologie NT - Pharmazie |
Professorship: | M - Prof. Dr. Markus Meyer NT - Prof. Dr. Alexandra K. Kiemer |
Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
File | Description | Size | Format | |
---|---|---|---|---|
metabolites-14-00342-v2.pdf | 1,32 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License